Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Design
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/164_2016_70
Reference89 articles.
1. Agusti A (2014) The path to personalised medicine in COPD. Thorax 69:857–864
2. Anderson WJ, Short PM, Williamson PA, Lipworth BJ (2012) Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENO type trial. Chest 142:1553–1561
3. Arron JR, Choy DF, Scheerens H, Matthews JG (2013) Non-invasive biomarkers that predict treatment benefit from biologic therapies in asthma. Ann Am Thorac Soc 10(Suppl):S206–S213
4. Aul R, Armstrong J, Duvoix A, Lomas D, Hayes B, Miller BE, Jagger C, Singh D (2012) Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. Br J Clin Pharmacol 74:1023–1032
5. Aul R, King H, Kolsum U, Singh D (2013) The reproducibility of bolus allergen challenges; power calculations for clinical trials. Eur J Clin Pharmacol 69:1187–1188
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New Drugs for Airway Diseases;Encyclopedia of Respiratory Medicine;2022
2. Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease;Frontiers in Pharmacology;2020-02-06
3. Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine;Value in Health;2019-03
4. A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD;Expert Opinion on Pharmacotherapy;2017-11-15
5. An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?;Expert Review of Respiratory Medicine;2017-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3